Literature DB >> 16867353

HPLC method for the simultaneous determination of beta-carotene, retinol and alpha-tocopherol in serum.

R K Aaran1, T Nikkari.   

Abstract

A method is described for the simultaneous analysis of alpha-tocopherol, beta-carotene, and retinol in n-hexane extracts of serum. The technique uses normal-phase HPLC in a silica gel column with n-hexane-2-propanol (97:3, v/v) as the mobile phase. The compounds are eluted from the column in the order alpha-tocopherol, beta-carotene, tocol (internal standard) and retinol. The compounds are quantified by use of the following detectors connected in series: retinol and tocol by a spectrophotometer, beta-carotene by a filter photometer, and alpha-tocopherol and tocol by a spectrophotofluorimeter. The time taken for separation is less than 6 min but a further 14 min is allowed for elution of the more polar compounds before the next run. With an automatic injector, the method is suitable for the analysis of a large number of samples because of the relatively short time for analysis and the small volume (0.2 ml) of serum required. The method has been used in a study of the relationships between serum levels of the fat-soluble vitamins and subsequent cancer in 2332 subjects.

Entities:  

Year:  1988        PMID: 16867353     DOI: 10.1016/0731-7085(88)80101-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Serum antioxidants and risk of rheumatoid arthritis.

Authors:  M Heliövaara; P Knekt; K Aho; R K Aaran; G Alfthan; A Aromaa
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

2.  Serum antioxidant vitamins and risk of cataract.

Authors:  P Knekt; M Heliövaara; A Rissanen; A Aromaa; R K Aaran
Journal:  BMJ       Date:  1992-12-05

3.  Serum ceruloplasmin and the risk of cancer in Finland.

Authors:  P Knekt; A Aromaa; J Maatela; A Rissanen; M Hakama; R K Aaran; T Nikkari; T Hakulinen; R Peto; L Teppo
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.